MRNA - Moderna Inc. (MRNA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
2024-06-10 15:47:08 ET
Moderna, Inc. (MRNA)
Goldman Sachs 45th Annual Global Healthcare Conference
June 10, 2024, 01:20 PM ET
Company Participants
Stephen Hoge - President
Conference Call Participants
Salveen Richter - Goldman Sachs
Presentation
Salveen Richter
Great. Good afternoon, everyone. Thank you so much for joining us. Really pleased to have Stephen Hoge, President of Moderna with us this morning.
Stephen Hoge
Thanks for having us.
Question-and-Answer Session
Q - Salveen Richter
After having just announced some news today on the COVID-flu combo, perhaps before we get into that, some big-picture questions, Moderna has over 40 programs in development. And in the context of R&D spend management, what is your strategy for pipeline prioritization?
Stephen Hoge
Great question. So, well, thank you, first of all. It's really exciting to be here, the first time in Miami with you too. So, first on the question of prioritization, as you know well, because you've followed us for years, we are a platform company.
And so we actually start with the question of what can our platform technology, which in our case is messenger RNA, what can it do? And we don't sort of say what we'd like it to do, we say, what are the pharmacology that it can do now. And as we've articulated, including our last R&D Day, there are really four pillars where we think our technology is mature and we're scaling, we call them modalities....
Moderna, Inc. (MRNA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)